Kearns, T., Cornally, N. At present, the evidence base for EoL care is founded on cancer care. This review highlights the paucity of studies that evaluate quality of EoL care for patients with chronic disease outside the established cancer-acute care paradigm, particularly in LTC. This review highlights the absence of any PROMs for the estimated 60% of patients in LTC with cognitive impairment. Patient-reported outcomes (PROs) are critical to understanding how EoL care services and practices affect patients' health and EoL experience. PROMs describe the quality of care from the patient's perspective and add balance to existing clinical or proxy-derived knowledge on the quality of care and services provided.
Rationale
By 2050, there will be 392 million people worldwide aged 80 years and over; more than three times the current number [3] . In developed countries, this demographic transition is underpinned by an epidemiological transition from high infant and maternal mortality, and high infectious disease rates, to low premature mortality and a predominance of chronic, non-communicable disease [4] . In congruence with population ageing, societies are ageing, and social environments are changing. Traditional, family-based options for EoL care are becoming less common [5] . Family size is decreasing and perspectives on intergenerational care of older people are shifting [6] . People are dying later in life, increasingly from chronic disease, and more frequently in LTC than at home [7] .
Chronic diseases include cardiovascular disease, hypertension, stroke, cancer, diabetes, arthritis, chronic obstructive pulmonary disease (COPD), dementia, and depression. Cardiovascular diseases account for the majority (46%) of chronic disease deaths globally, followed by cancers (22%), respiratory diseases (10.5%) and diabetes (4%) [8] .The prevalence of these diseases typically increases with age, and multi-morbidity is a common feature. Approximately 80% of older adults have at least one chronic disease, and 68% have at least two [9] . Chronic diseases are the leading cause of mortality worldwide, representing 60% of all deaths globally [10] .
The proportion of U.S. deaths in LTC was 23% in 2008, this figure is projected to rise to 40% by 2040 [11] . This trend is mirrored elsewhere, in New Zealand [12] , Australia [13] , Canada [14] , Ireland [7] , and the U.K. [6] . A study of prevalence of chronic medical conditions in older residents in LTC in the U.S. found that the leading three chronic diseases were; hypertension (men 53%, women 56%), dementia (men 45%, women 52%), and depression (men 31%, women 37%) [15] . A study of patterns of chronic co-morbid medical conditions in older residents in LTC in the U.S. found that the most frequent two co-morbid disease combination in both men and women was hypertension and dementia [16] . It is estimated that as many as 60% of patients in LTC have cognitive impairment or dementia, many of whom do not have a formal diagnosis [17] [18] [19] [20] .
Evaluating EoL care for patients with cancer presents fewer methodological challenges than for other chronic disease populations. In comparison to other leading chronic diseases, cancer has a more predictable trajectory towards death, and more certainty in prognostication [21] [22] [23] . Consequently, much of the research todate in evaluating EoL care has focused on patients with cancer in its associated care settings. Originally, PROMs of EoL care focused on the evaluation of physical symptoms, recently, their scope has broadened to include psycho-social factors, well-being, spirituality, mental health, communication and quality of life [24] . There are several condition-specific PROMs for patients with different types of cancer; typically these measures focus on symptoms such as pain, dyspnea, and nausea, in addition to subjective aspects of the patients' experience of EoL care.
While many of the physical symptoms experienced by cancer patients are common to other chronic disease populations, the patient experience at EoL is often different. Patients with nonmalignant disease experience more burdensome symptoms in the last year of life than those suffering from cancer, not only because of the greater number of symptoms, but also because of the more protracted trajectory of decline in chronic conditions [25, 26] . A gradual deterioration in functioning, punctuated by intermittent acute episodes is typical in conditions such as COPD and heart failure. Frail elderly patients and those with dementia typically experience a prolonged and progressive functional decline from an already low baseline of physical and cognitive function [27] . As a result, many of these patients use multiple healthcare settings for EoL care.
Objectives
Currently, the evidence base for EoL care is founded on the cancer-acute care paradigm [28] . Development of the evidence base necessitates measurement of the patient experience beyond these confines. The objectives of this review were to identify, describe and critically evaluate existing PROMs of quality of EoL care, for patients with chronic disease, in various healthcare settings.
Methods

Eligibility criteria
Papers were identified based on the following inclusion criteria: The following exclusion criteria were used:
1. Studies based on samples where cancer is the sole diagnosis 2. Clinical trials and studies addressing technical interventions, physiological, laboratory-based, or radiological outcomes 3. Descriptive, non-clinical articles (e.g., reviews, discussion pieces, reports, expert statements)
Information sources and searches
A systematic review of the literature was conducted during July 2016. Searches were conducted in Academic Search Complete, CINAHL Plus with full text, PsycINFO, Scopus, Web of Science, PubMed, and Cochrane databases. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Guidelines were used in this systematic review [29] . The search strategy included a combination of free text and controlled vocabulary (MeSH) terms. The search strategy used three groups of terms combined with AND: "end of life care", "patient reported outcomes", and "scale". Details of the electronic search strategy, including search terms used are shown in Table 1 . The grey literature was searched using Open Grey and Google Scholar databases.
Studies were examined for inclusion in a two-step process, with an initial screening of titles and abstracts, followed by screening of full-text articles against the inclusion criteria to identify relevant studies. Searches in EBSCO and PubMed were saved and updated with weekly alerts and RSS feeds from July to September 2016 to ensure that any eligible studies published subsequent to the final search date were not missed. No further studies were identified for inclusion via alerts or feeds. Data was extracted from the identified articles and tabulated according to author and date, characteristics of the studies and key features of the measures used.
The measures used in the identified studies were reviewed and psychometrically evaluated according to quality criteria adapted from Terwee et al., [30] and Selman et al., [31] . Specific adaptations made were as follows: due to the lack of an agreed 'gold standard' for PROs of quality of care, criterion validity was not assessed; as the instruments reviewed were patient-reported, inter-rater agreement was deemed not to be relevant and test-retest reliability was used as a more appropriate test of reliability; as no scoring system was used, the quality criterion for 'no information found' was given a not reported (NR) rating instead of 0; the term 'doubtful' in the criteria for indeterminate rating was changed to 'inadequate'; due to the complexity of defining minimally important change (MIC) for quality of care, the requirement that the MIC be defined to satisfy the interpretability criterion was omitted. The adapted criteria used are shown in Table 2 .
Results
Study selection
The database searches yielded 966 articles, searches of the grey literature, journals, reviews, and the Internet resulted in an additional 75 articles, yielding a total of 1041 articles. Eliminating duplicates gave a total of 940 articles for screening. The total number of articles retained post-screening was 24, the full text of these articles was retrieved and reviewed for final eligibility. Twelve articles were excluded for the following reasons: not based on PROs (n = 1), not EOL care (n = 3), based exclusively on sample of patients with cancer (n = 4), did not report or describe psychometric properties of assessment used (n = 3), was a descriptive/non clinical article (n = 1). A total of 12 studies were included in the final review. A flowchart of the stages of the review process according to the PRISMA guidelines is shown in Fig. 1 .
Study characteristics
Of the 12 studies included in the review, six were primary research studies and six were validation studies. The studies were based in a range of settings, three in hospitals; three in community settings; four in multiple settings; and two in hospice settings. The patients sampled had a variety of diagnoses, two studies were based on patients with Multiple Sclerosis (MS); two on patients with HIV/AIDS; three on patients with unspecified chronic disease; and five on palliative care patients, predominantly, but not exclusively with a cancer diagnosis.
A total of 15 PROMs of quality of EoL care in patients with chronic disease were identified across the 12 studies included. Study characteristics, PROMs used, and their key features are shown in Tables 3 and 4 . The majority of measures used five or eleven-point Likert rating scales and reported administration times of 10 min or less. The exception was the MCOHPQ, with a reported administration time of 25-30 min. Administration time for the Quality Measure for Palliative Nursing was not reported.
Synthesis of results
The psychometric properties of the included measures, evaluated according to criteria adapted from Terwee et al. [30] and Selman et al. [31] are presented in Table 5 . Of the 15 measures evaluated, ten demonstrated adequate content validity. No information on target population involvement was found for the MCOHPQ, and the remaining four measures had an indeterminate rating as they lacked a clear description of the development process.
Six measures demonstrated adequate internal consistency. Three of the measures, the PHQ-9, the SKIPP and the MVQOLI, had an indeterminate rating for internal consistency, predominantly due to a lack of factor analysis. Five measures showed poor internal consistency: the MCOHPQ, the QOC, the SEC-P and the African POS. No information on internal consistency was found for the Quality Measure for Palliative Nursing.
Nine of the measures demonstrated adequate construct validity. Testing of three measures used an inadequate design or method. The SEC-P demonstrated poor construct validity, and no information on construct validity was found for the MCOHPQ and the Quality Measure for Palliative Nursing.
Seven measures, the POS, the MSIS, the SAS, the PHQ, the HADS-D, the BHI, and the African POS, demonstrated adequate test-retest reliability. Test-retest reliability was indeterminate for the SKIPP due to doubtful design in testing. No information on test-retest reliability was found for the remaining seven of the fifteen measures.
No information on responsiveness was available for eight measures. The PHQ and the HADS-D both demonstrated adequate responsiveness. Of the remaining five measures four had [30] . MIC = minimal important change; SDC = smallest detectable change; LOA = limits of agreement; ICC = Intraclass correlation; SD, standard deviation. a + = positive rating; ? = indeterminate rating; − = negative rating; NR = not reported. b Inadequate design or method = lacking of a clear description of the design or methods of the study, sample size smaller than 50 subjects (should be at least 50 in every (subgroup) analysis), or any important methodological weakness in the design or execution of the study.
an indeterminate rating and one, the SEC-P, demonstrated poor responsiveness.
No information on floor and ceiling effects was found for eight of the measures reviewed. Five measures demonstrated floor/ceiling effects despite adequate design and methods. Two measures, the POS-MSS and the MVQoLI demonstrated low floor/ceiling effects.
One measure, the SAS demonstrated adequate interpretability. No information on interpretability was found for eleven of the measures and three had an indeterminate rating.
Discussion
The aim of this review was to identify, describe and critically evaluate existing PROMs of quality of EoL care for patients with chronic disease, in various healthcare settings. A total of 15 PROMs of quality of EoL care in patients with chronic disease were identified across 12 studies.
Summary of evidence
The measures identified were heterogeneous in terms of their constituent domains. Physical symptoms and perceptions of quality of care or experiences of care were the most frequently occurring domains, with both occurring in nine of the 15 measures identified. Quality of life (QoL) or well-being featured as a domain in five measures, emotional/psychosocial symptoms featured in five measures, spiritual status featured in three measures, anxiety/depression featured in three measures and healthcare professionals' communication skills featured in three measures. These findings highlight that there is broad agreement across the PROMs identified, in that the evaluation of quality of EoL care requires multidimensional PROMs, encompassing both subjective and objective indicators. However, these findings also demonstrate the absence of consensus on what the essential, core domains for measurement should be.
The majority of studies were conducted in a single setting, with mixed, cancer-predominant populations. None of the studies identified were based in LTC settings. However, a small number (n = 3) of the patients sampled in Higginson's study [38] were nursing home residents.
None of the measures identified included patients with cognitive impairment in their validation study samples. The BHI, POS, SEC-P, QEOLC and QOC, all specify exclusion of patients with cognitive impairment in their validation study samples. Cognitive impairment was not specified as an exclusion criterion for the remaining measures; however various inclusion criteria used, such as the ability to remember and report [35] , and to be mentally wellenough [42] act as de facto barriers to participation from patients with cognitive impairment. No cognitive impairment/dementiaspecific PROMs were identified, and no adaptations of the PROMs identified for use with patients with cognitive impairment were reported. The POS, a generic mutidimensional PROM was found to be one of the more robust measures identified, with good content validity, internal consistency, construct validity and test-retest reliability. The POS was the only measure reviewed that was used in a research study that included patients with cognitive impairment in the study sample, although the number of such participants was not reported [38] . The POS-MS, a version of the POS adapted for use with patients with MS, demonstrates good psychometric properties for validity criteria and floor and ceiling effects, however, the small sample size and lack of data for reliability and responsiveness indicate that further testing and validation is required.
Based on a large validation sample of over 1000 patients with Multiple Sclerosis (MS), the MSIS shows a strong psychometric profile with respect to validity and reliability. However, the measure's condition specificity may limit its adaptation and use in other chronic disease populations. The QEOLC also shows good psychometric properties for content and construct validity and internal consistency. However, further testing of its test-retest reliability and responsiveness are required.
The majority of the validation study samples of the included measures are small, with samples of less than 250 subjects [65] . The measures with the smallest validation study sample sizes, the SKIPP (n = 35), and the Quality Measure for Palliative Nursing (n = 11), both score poorly on the quality criteria used. This inevitably raises questions regarding design adequacy and methodological strength. However, as both measures are relatively new, further testing of validity and reliability is required.
Responsiveness is an important property in PROMs for evaluating quality of EoL care, yet only two measures, the PHQ and the HADS, demonstrated adequate responsiveness. Both are unidimensional measures of anxiety and depression symptoms, where significant change may be more easily quantified (using SDC, MIC, or GRR) than for multidimensional measures.
Overall, the measures evaluated were found to lack psychometric quality and methodological rigor. However, a number of considerations need to be made when evaluating PROMs of EoL care. The difficulty in defining what is minimal important change (MIC) for this population, impacts on the application of the responsiveness and interpretability criteria. Floor and ceiling effects are relevant only where the measure under consideration has a total score or subscale scores. Additionally, the methodological challenges inherent in carrying out research with patients at EoL with chronic disease, frequently preclude the recruitment and retention of the large study samples required for factor analyses.
Another consideration is the difference in the constructs measured across the various measures identified. The POS, African POS, MCOHPQ, QEOLC, BHI, MVQOLI and the SKIPP are generic, multidimensional PROMS that measure quality of care in relation to general health or well-being; the POS-MS and MSIS are conditionspecific PROMS that measure quality of care in relation to MS symptoms; the SAS, PHQ-8 and HADS are symptom-specific, unidimensional measures; and the QOC, SEC and Quality Measure for Palliative Nursing measure communication, patients' sense of security and nursing skills, respectively. The time-frame across which quality of care was measured also varied, ranging from 'current perception' to 'in the last 6 months'. These disparities pose a challenge in drawing clear comparisons among the measures included in this review, and as such they were evaluated individually with respect to their psychometric properties.
A significant limitation of this review is that only articles written in English were included, and important studies in other languages may have been omitted as a result. Additionally, the limit on publication dates from 2006 to 2016 may have excluded additional relevant studies. Finally, a review of the qualitative literature would have enhanced the clarity of the theoretical bases for the concept of quality of care and its related constructs, but was beyond the scope of this review.
The findings of this review underline the lack of PROMS of EoL care for patients with chronic disease outside the cancer care model, and the absence of any PROMs of EoL care developed or validated for use with patients with cognitive impairment. Further research is required to develop of a core set of PROs for use with patients with non-malignant chronic disease, across multiple EoL care settings and disease trajectories.
Conclusion
Extension of the current evidence base requires further research to develop and adapt PROMs for the growing population of patients with chronic disease who reside in non-acute care settings, particularly in LTC.
The inherent methodological challenges in evaluating EoL care in this population necessitate the development of alternative methods of assessment and appraisal. Given the proportion of patients in LTC with cognitive impairment, the development of appropriate PROMs for this population will require the inclusion of these patients in study samples and the adaptation of measures to suit participants with varying levels of cognition.
This review highlights the need for a high quality PROM of quality of EoL care for patients with chronic disease beyond the established acute care-cancer paradigm, to include patients with varying levels of cognition. The development of a wider selection of context sensitive, methodologically sound and psychometrically robust PROMs is an essential step towards improving the quality of EoL care for our ageing populations and chronically ill.
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